fbpx
March 22, 2024

Piperacillin Tazobactam – Injection products

Recognized Interpretive Criteria FDA Identified Interpretive Criteria Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S SDDa I R S SDDa I R Enterobacteralesb ≤8/4 – […]
March 22, 2024

Ceftazidime – Injection products

Recognized Interpretive Criteria Exceptions to the recognized standard of CLSI M100 Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacterales […]
March 22, 2024

FDA Drug Competition Action Plan

Bringing more drug competition to the market is a top priority of the Administration, the Department of Health and Human Services (HHS), and FDA. In 2017, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0